Reports for SANDOZ CANADA INCORPORATED

Company Name

SANDOZ CANADA INCORPORATED

Totals

Shortage reports

1839

Actual shortage: 46 (3%)
Anticipated shortage: 1 (0%)
Avoided shortage: 13 (1%)
Resolved: 1779 (97%)

Discontinuation Reports

82

To be discontinued: 1 (1%)
Discontinued: 79 (96%)
Reversed: 2 (2%)

Late reports

439 (23%)

Overdue reports

1 (2%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ IRBESARTAN 150MG TABLET Resolved 2023-10-23 2023-10-31 207764
SANDOZ IRBESARTAN HCT 25MG 300MG TABLET Resolved 2017-03-14 2017-05-08 2705
SANDOZ IRBESARTAN HCT 25MG 300MG TABLET Resolved 2017-09-07 2017-10-25 21284
SANDOZ IRBESARTAN HCT 150MG 12.5MG TABLET Resolved 2020-09-21 2020-10-27 124600
SANDOZ IRBESARTAN HCT 150MG 12.5MG TABLET Resolved 2020-09-21 2020-10-27 124606
SANDOZ IRBESARTAN HCT 300MG 12.5MG TABLET Resolved 2020-09-21 2020-10-27 124609
SANDOZ IRBESARTAN HCT 300MG 12.5MG TABLET Resolved 2020-09-21 2020-10-27 124612
SANDOZ IRBESARTAN HCT 300MG 25MG TABLET Resolved 2020-09-21 2020-10-27 124617
SANDOZ IRBESARTAN HCT 300MG 25MG TABLET Resolved 2020-09-21 2020-10-27 124621
SANDOZ IRBESARTAN HCT 150MG 12.5MG TABLET Resolved 2020-11-27 2020-12-09 129102
SANDOZ IRBESARTAN HCT 150MG 12.5MG TABLET Resolved 2021-01-12 2021-03-08 131394
SANDOZ IRBESARTAN HCT 25MG 300MG TABLET Resolved 2021-10-19 2021-10-26 147570
SANDOZ IRBESARTAN HCT 25MG 300MG TABLET Resolved 2023-02-14 2023-03-28 184632
SANDOZ IRBESARTAN HCT 12.5MG 300MG TABLET Resolved 2023-03-06 2023-03-28 186285
SANDOZ IRBESARTAN HCT 12.5MG 150MG TABLET Resolved 2023-03-13 2023-04-18 186967
SANDOZ IRBESARTAN HCT 12.5MG 150MG TABLET Resolved 2023-03-13 2023-05-03 186971
SANDOZ IRBESARTAN HCT 25MG 300MG TABLET Resolved 2023-07-31 2024-01-09 200534
SANDOZ IRBESARTAN HCT 12.5MG 300MG TABLET Resolved 2023-08-07 2023-08-15 201264
SANDOZ IRBESARTAN HCT 25MG 300MG TABLET Resolved 2023-09-19 2024-01-09 204738
SANDOZ IRBESARTAN HCT 12.5MG 300MG TABLET Resolved 2023-12-04 2024-01-18 212445

Showing 1181 to 1200 of 1839

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
SANDOZ ALENDRONATE 10MG TABLET Discontinued 2019-11-19 2019-11-19 99259
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
SODIUM AUROTHIOMALATE INJECTION BP 50MG SOLUTION Discontinued 2018-07-13 2018-07-13 55768
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
SANDOZ DILTIAZEM T Discontinued 2020-04-01 2020-04-01 110324
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
SANDOZ FINASTERIDE A 1MG TABLET Discontinued 2023-06-30 2023-07-01 196983
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467

Showing 1 to 20 of 82